* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Gene Section NET1 (neuroepithelial cell transforming gene 1) in Oncology and Haematology
History of genetic engineering wikipedia , lookup
Gene therapy wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Frameshift mutation wikipedia , lookup
Gene expression profiling wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Protein moonlighting wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Gene nomenclature wikipedia , lookup
Genome (book) wikipedia , lookup
Genetic code wikipedia , lookup
Microevolution wikipedia , lookup
Expanded genetic code wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Helitron (biology) wikipedia , lookup
Designer baby wikipedia , lookup
Oncogenomics wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Mini Review NET1 (neuroepithelial cell transforming gene 1) David Murray, Peter Doran UCD School of Medicine and Medical Sciences, UCD-Mater Clinical Research Centre, Mater Misericordiae University Hospital, Dublin 7, Ireland (DM, PD) Published in Atlas Database: April 2008 Online updated version : http://AtlasGeneticsOncology.org/Genes/NET1ID41526ch10p15.html DOI: 10.4267/2042/44429 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2009 Atlas of Genetics and Cytogenetics in Oncology and Haematology 121 qsftlrgdhr spasaqkfss rstvptpakr rssalwseml ditmkesltt reirrqeaiy 181 emsrgeqdli edlklarkay hdpmlklsim seeelthifg dldsyiplhe dlltrigeat 241 kpdgtveqig hilvswlprl nayrgycsnq laakalldqk kqdprvqdfl qrclespfsr 301 kldlwsfldi prsrlvkypl llkeilkhtp kehpdvqlle dailiiqgvl sdinlkkges 361 ecqyyidkle yldekqrdpr ieaskvllch gelrsksghk lyiflfqdil vltrpvtrne 421 rhsyqvyrqp ipvqelvled lqdgdvrmgg sfrgafsnse kaknifrirf hdpspaqsht 481 lqandvfhkq qwfnciraai apfqsagspp elqglpelhe ecegnhpsar kltaqrrast 541 vssvtqvevd enayrcgsgm qmaedskslk thqtqpgirr ardkalsggk rketlv. Identity Other names: ARHGEF8; NAT1; NET1A; SLC6A2 HGNC (Hugo): NET1 Location: 10p15.1 Local order: The NET1 gene is located on chromosome 10 in a 11832 bp sequence (5478574 to 5490426). DNA/RNA Description This gene, found on chromosome 10 at location 10p15 (5,444,518-5,490,401) encompasses 11832 bp of genomic DNA. The gene has 10 exons and the mRNA transcript is 3414 nucleotides in length. Expression This protein is widely expressed in mammalian tissue. Protein Localisation Description It is localized to both the cytoplasm and the nucleus. Function The protein encoded by this gene acts as guanine nucleotide exchange factor (gef) for RhoA gtpase. This gene encodes for a protein of 596 amino acids with a molecular weight of 67.74 kDa. The protein contains the following domains: a Rho guanine nucleotide exchange factor (RhoGEF) activity domain from amino acid 178 - 355 and a pleckstrin homology domain from amino acid 387-503. The 596 amino acid sequence is: Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPase. Homology Holomogy with Pan troglodytes (97%); Canis lupus familiaris (92%); Mus musculus (93%), Rattus norvegicus (92%), Gallus gallus (88%). 1 mepelaaqkq prprrrsrra sglstegatg psadtsgsel dgrcslrrgs sftfltpgpn 61 wdftlkrkrr ekdddvvsls sldlkepsnk rvrplarvts lanlispvrn gavrrfgqti Atlas Genet Cytogenet Oncol Haematol. 2009; 13(3) Mutations Note NET1 is subject to the following misense mutations: 213 NET1 (neuroepithelial cell transforming gene 1) Murray D, Doran P References Source ID: rs34821922 rs34658946 rs34821949 Wild type nucleotide: A T A Wild type amino acid: Chan AM, Takai S, Yamada K, Miki T. Isolation of a novel oncogene, NET1, from neuroepithelioma cells by expression cDNA cloning. Oncogene. 1996 Mar 21;12(6):1259-66 K I K Alberts AS, Treisman R. Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1. EMBO J. 1998 Jul 15;17(14):4075-85 Variant nucleotide: G C G Dobrosotskaya IY. Identification of mNET1 as a candidate ligand for the first PDZ domain of MAGI-1. Biochem Biophys Res Commun. 2001 May 18;283(4):969-75 R T E 28 363 466 Shen X, Li J, Hu PP, Waddell D, Zhang J, Wang XF. The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation. J Biol Chem. 2001 May 4;276(18):15362-8 Variant amino acid: Amino Acid Position: Alberts AS, Qin H, Carr HS, Frost JA. PAK1 negatively regulates the activity of the Rho exchange factor NET1. J Biol Chem. 2005 Apr 1;280(13):12152-61 Implicated in Qin H, Carr HS, Wu X, Muallem D, Tran NH, Frost JA. Characterization of the biochemical and transforming properties of the neuroepithelial transforming protein 1. J Biol Chem. 2005 Mar 4;280(9):7603-13 Gastric Cancer Disease Gastric or stomach cancer is a malignant epithelial malignancy of the stomach mucosa. The vast majority of gastric carcinomas are adenocarci nomas, arising from the gastric glandular epithelium. Prognosis Prognosis depends on the stage of the cancer. Because most stomach cancers are at an advanced stage upon diagnosis, the average 5 years survival rate is 12%. This is often due to the fact that the tumor has spread beyond the primary site. Oncogenesis NET1 has been shown to be up-regulated in Gastric Cancer (Leyden J et al., 2006). NET1 is a GEF exchange factor for Rho GTPase proteins (Alberts AS et al., 1998) and is therefore implicated in Rhomediated processes such as cytoskeletal organiza-tion and cell migration. NET1 has been shown to drive gastric tumor cell invasion (Leyden J et al., 2006). It is this aggressive phenotype of the disease that accounts for the dismal prognosis as the majority of gastric tumors are at an advanced stage upon diagnosis where they have spread beyond the primary site. Atlas Genet Cytogenet Oncol Haematol. 2009; 13(3) Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, Yamashita R, Yamamoto J, Sekine M, Tsuritani K, Wakaguri H, Ishii S, Sugiyama T, Saito K, Isono Y, Irie R, Kushida N, Yoneyama T, Otsuka R, Kanda K, Yokoi T, Kondo H, Wagatsuma M, Murakawa K, Ishida S, Ishibashi T, TakahashiFujii A, Tanase T, Nagai K, Kikuchi H, Nakai K, Isogai T, Sugano S. Diversification of transcriptional modulation: largescale identification and characterization of putative alternative promoters of human genes. Genome Res. 2006 Jan;16(1):5565 Leyden J, Murray D, Moss A, Arumuguma M, Doyle E, McEntee G, O'Keane C, Doran P, MacMathuna P. Net1 and Myeov: computationally identified mediators of gastric cancer. Br J Cancer. 2006 Apr 24;94(8):1204-12 García-Mata R, Dubash AD, Sharek L, Carr HS, Frost JA, Burridge K. The nuclear RhoA exchange factor Net1 interacts with proteins of the Dlg family, affects their localization, and influences their tumor suppressor activity. Mol Cell Biol. 2007 Dec;27(24):8683-97 This article should be referenced as such: Murray D, Doran P. NET1 (neuroepithelial cell transforming gene 1). Atlas Genet Cytogenet Oncol Haematol. 2009; 13(3):213-214. 214